Echosense Ltd.

ACTIVE

Israelwww.echosense.co.ilPrivate1–10 employeesEstablished: 2006-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2006

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

36.8%

Phase 1

5.3%

Trial Status Distribution

Completed

26.3%

Terminated

52.6%

Withdrawn

21.1%

Clinical Trials

Trials sponsored by this organization (19)

Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea

Not Applicable

Terminated

interventional

Sep 2019130 participants

Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)

Evaluation of Cardiopulmonary Diseases by Ultrasound

Not Applicable

Completed

interventional

Sep 2014600 participants

Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound

Not Applicable

Terminated

interventional

Sep 20141 participant

Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)

Not Applicable

Terminated

interventional

Sep 20145 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations

Echosense Ltd.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (19)

Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea

Diagnosis of Pulmonary Embolism by Doppler Signals

Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis

Evaluation of Lung Doppler Signals in Patients Presenting to EMD

Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)

Evaluation of Cardiopulmonary Diseases by Ultrasound

Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound

Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)

Approvals

News